fifteen patients received either feiba or the control preparation ( a nonactivated prothrombin-complex concentrate ) for a total of 150 bleeding episodes ( four mucocutaneous bleeding , 117 joint bleeding , and 29 muscle bleeding ) .
C0018924
joint bleeding
C0019080
bleeding